News
6h
The Print on MSNObesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approachAs obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
Referral to catheter ablation should not be delayed until the patient loses weight, say researchers for the PRAGUE-25 trial. But experts highlight the positive results for lifestyle changes in the ...
Lifestyle therapy may not be enough to improve outcomes for patients with HF and obesity, but careful risk evaluation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results